Affiliation:
1. Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern
2. CSL Behring AG, Wankdorfstrasse 10, 3000 Bern 22, Switzerland
Abstract
ABSTRACT
The unique region of the capsid protein VP1 (VP1u) of B19 virus (B19V) elicits a dominant immune response and has a phospholipase A
2
(PLA
2
) activity required for the infection. Despite these properties, we have observed that the VP1u-PLA
2
motif occupies an internal position in the capsid. However, brief exposure to increasing temperatures induced a progressive accessibility of the PLA
2
motif as well as a proportional increase of the PLA
2
activity. Similarly, upon binding on human red blood cells (RBCs), a proportion of the capsids externalized the VP1u-PLA
2
motif. Incubation of B19V with RBCs from 17 healthy donors resulted in extensive virus attachment ranging between 3,000 and 30,000 virions per cell. B19V empty capsids represent an important fraction of the viral particles circulating in the blood (30 to 40%) and bind to RBCs in the same way as full capsids. The extensive B19V binding to RBCs did not cause direct hemolysis but an increased osmotic fragility of the cells by a mechanism involving the PLA
2
activity of the exposed VP1u. Analysis of a blood sample from an individual with a recent B19V infection revealed that, at this particular moment of the infection, the virions circulating in the blood were mostly associated to the RBC fraction. However, the RBC-bound B19V was not able to infect susceptible cells. These observations indicate that RBCs play a significant role during B19V infection by triggering the exposure of the immunodominant VP1u including its PLA
2
constituent. On the other hand, the early exposure of VP1u might facilitate viral internalization and/or uncoating in target cells.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference45 articles.
1. Anderson, M. J., S. E. Jones, S. P. Fisher-Hoch, E. Lewis, S. M. Hall, C. L. R. Bartlett, B. J. Cohen, P. P. Mortimer, and M. S. Pereira. 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lett. Lancet1:1378.
2. Anderson, S., M. Momoeda, M. Kawase, S. Kajigaya, and N. S. Young. 1995. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology206:626-632.
3. Mutational Analysis of Narrow Pores at the Fivefold Symmetry Axes of Adeno-Associated Virus Type 2 Capsids Reveals a Dual Role in Genome Packaging and Activation of Phospholipase A2 Activity
4. Brown, K. E., S. M. Anderson, and N. S. Young. 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science262:114-117.
5. Brown, T., A. Anand, L. D. Ritchie, J. P. Clewley, and T. M. Reid. 1984. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet2:1033-1034.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献